Inside INdiana Business

McKinsey & Company settles lawsuit

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A bipartisan congressional investigation released Wednesday, Dec. 16, 2020, found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers. (AP Photo/Toby Talbot, File)

INDIANAPOLIS (Inside INdiana Business) — The state of Indiana is receiving $12.5 million in a settlement from McKinsey & Company, which resolves investigations into the company’s efforts working for opioid manufacturers. Indiana Attorney General Todd Rokita says it is the first multi-state opioid settlement to result in large payments to states to address the opioid epidemic.

Rokita says the settlement filing outlines how McKinsey spurred the opioid crisis by selling marketing schemes and consulting services to opioid manufacturers, including Purdue Pharma, to encourage doctors to over-prescribe OxyContin.

“We owe it to Hoosier families to hold those responsible for this crisis accountable and deliver the justice they deserve. I want to thank the attorneys in my office who have worked tirelessly to reach this historic settlement, which will bring substantial and immediate relief to communities across the state,” said Rokita.

Rokita says Indiana’s share of the $573 million settlement will be used for prevention, education and treatment efforts. The settlement also calls for McKinsey to stop advising companies on certain Schedule II and III narcotics.

Indiana was joined in the settlement by 46 other states, Washington, D.C. and five U.S. territories.